Expertise in
2
conditions

Gordana Djordjevic

Nis, SE, RS 
Expertise in
2
conditions
Nis, SE, RS 

Overview

Gordana Djordjevic practices practicing medicine in Nis, Serbia.

Ms. Djordjevic is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Guillain-Barre Syndrome, Chronic Polyradiculoneuritis, Chronic Inflammatory Demyelinating Polyneuropathy, and Primary Lateral Sclerosis.

She is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Nis, SE, Serbia
Other Locations
Novi Sad, VO, Serbia
Kragujevac, SE, Serbia
Serbia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR-FAP): An International, Multicenter, Epidemiological Protocol
Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR-FAP): An International, Multicenter, Epidemiological Protocol
Enrollment Status: Completed
Publish Date: June 06, 2022
View 1 Less Clinical Trial

17 Total Publications

Quality of sleep in chronic migraine patients treated with fremanezumab - 6 months follow-up.
Quality of sleep in chronic migraine patients treated with fremanezumab - 6 months follow-up.
Journal: Clinical neurology and neurosurgery
Published: October 11, 2025

Frequently Asked Questions about Gordana Djordjevic

Is Gordana Djordjevic a top-rated expert for Guillain-Barre Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Gordana Djordjevic is classified as an Advanced expert for Guillain-Barre Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gordana Djordjevic participate in research or clinical trials?

Yes. Gordana Djordjevic has published 17 articles and abstracts on conditions like Guillain-Barre Syndrome. You can view a list of Gordana Djordjevic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Djordjevic's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile